242 related articles for article (PubMed ID: 34519578)
1. Biologic Pathways Underlying Prognostic Radiomics Phenotypes from Paired MRI and RNA Sequencing in Glioblastoma.
Sun Q; Chen Y; Liang C; Zhao Y; Lv X; Zou Y; Yan K; Zheng H; Liang D; Li ZC
Radiology; 2021 Dec; 301(3):654-663. PubMed ID: 34519578
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.
Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z
Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Core Signaling Pathway by Using Diffusion- and Perfusion-based MRI Radiomics and Next-generation Sequencing in Isocitrate Dehydrogenase Wild-type Glioblastoma.
Park JE; Kim HS; Park SY; Nam SJ; Chun SM; Jo Y; Kim JH
Radiology; 2020 Feb; 294(2):388-397. PubMed ID: 31845844
[TBL] [Abstract][Full Text] [Related]
4. Radiomics may increase the prognostic value for survival in glioblastoma patients when combined with conventional clinical and genetic prognostic models.
Choi Y; Nam Y; Jang J; Shin NY; Lee YS; Ahn KJ; Kim BS; Park JS; Jeon SS; Hong YG
Eur Radiol; 2021 Apr; 31(4):2084-2093. PubMed ID: 33006658
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Prognosis in Glioblastoma Using Radiomics Features of Dynamic Contrast-Enhanced MRI.
Pak E; Choi KS; Choi SH; Park CK; Kim TM; Park SH; Lee JH; Lee ST; Hwang I; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH
Korean J Radiol; 2021 Sep; 22(9):1514-1524. PubMed ID: 34269536
[TBL] [Abstract][Full Text] [Related]
6. Radiomic profiling for insular diffuse glioma stratification with distinct biologic pathway activities.
Duan W; Wang Z; Ma Z; Zheng H; Li Y; Pei D; Wang M; Qiu Y; Duan M; Yan D; Ji Y; Cheng J; Liu X; Zhang Z; Yan J
Cancer Sci; 2024 Apr; 115(4):1261-1272. PubMed ID: 38279197
[TBL] [Abstract][Full Text] [Related]
7. Multiregional radiomics profiling from multiparametric MRI: Identifying an imaging predictor of IDH1 mutation status in glioblastoma.
Li ZC; Bai H; Sun Q; Zhao Y; Lv Y; Zhou J; Liang C; Chen Y; Liang D; Zheng H
Cancer Med; 2018 Dec; 7(12):5999-6009. PubMed ID: 30426720
[TBL] [Abstract][Full Text] [Related]
8. Imaging phenotypes from MRI for the prediction of glioma immune subtypes from RNA sequencing: A multicenter study.
Duan J; Zhang Z; Chen Y; Zhao Y; Sun Q; Wang W; Zheng H; Liang D; Cheng J; Yan J; Li ZC
Mol Oncol; 2023 Apr; 17(4):629-646. PubMed ID: 36688633
[TBL] [Abstract][Full Text] [Related]
9. A radiomics nomogram based on multiparametric MRI might stratify glioblastoma patients according to survival.
Zhang X; Lu H; Tian Q; Feng N; Yin L; Xu X; Du P; Liu Y
Eur Radiol; 2019 Oct; 29(10):5528-5538. PubMed ID: 30847586
[TBL] [Abstract][Full Text] [Related]
10. Biological underpinnings of radiomic magnetic resonance imaging phenotypes for risk stratification in IDH wild-type glioblastoma.
Guan F; Wang Z; Qiu Y; Guo Y; Pei D; Wang M; Xing A; Liu Z; Yu B; Cheng J; Liu X; Ji Y; Yan D; Yan J; Zhang Z
J Transl Med; 2023 Nov; 21(1):841. PubMed ID: 37993907
[TBL] [Abstract][Full Text] [Related]
11. Multiparametric MRI-based fusion radiomics for predicting telomerase reverse transcriptase (TERT) promoter mutations and progression-free survival in glioblastoma: a multicentre study.
Zhang H; Zhang H; Zhang Y; Zhou B; Wu L; Yang W; Lei Y; Huang B
Neuroradiology; 2024 Jan; 66(1):81-92. PubMed ID: 37978079
[TBL] [Abstract][Full Text] [Related]
12. Radiomic MRI Phenotyping of Glioblastoma: Improving Survival Prediction.
Bae S; Choi YS; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
Radiology; 2018 Dec; 289(3):797-806. PubMed ID: 30277442
[TBL] [Abstract][Full Text] [Related]
13. A radiomics-clinical nomogram for preoperative prediction of IDH1 mutation in primary glioblastoma multiforme.
Su X; Sun H; Chen N; Roberts N; Yang X; Wang W; Li J; Huang X; Gong Q; Yue Q
Clin Radiol; 2020 Dec; 75(12):963.e7-963.e15. PubMed ID: 32921406
[TBL] [Abstract][Full Text] [Related]
14. Multiregional radiomics features from multiparametric MRI for prediction of MGMT methylation status in glioblastoma multiforme: A multicentre study.
Li ZC; Bai H; Sun Q; Li Q; Liu L; Zou Y; Chen Y; Liang C; Zheng H
Eur Radiol; 2018 Sep; 28(9):3640-3650. PubMed ID: 29564594
[TBL] [Abstract][Full Text] [Related]
15. Volume of high-risk intratumoral subregions at multi-parametric MR imaging predicts overall survival and complements molecular analysis of glioblastoma.
Cui Y; Ren S; Tha KK; Wu J; Shirato H; Li R
Eur Radiol; 2017 Sep; 27(9):3583-3592. PubMed ID: 28168370
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced MRI radiomics model predicts epidermal growth factor receptor amplification in glioblastoma, IDH-wildtype.
Sohn B; Park K; Ahn SS; Park YW; Choi SH; Kang SG; Kim SH; Chang JH; Lee SK
J Neurooncol; 2023 Sep; 164(2):341-351. PubMed ID: 37689596
[TBL] [Abstract][Full Text] [Related]
17. Radiogenomics to characterize the immune-related prognostic signature associated with biological functions in glioblastoma.
Liu D; Chen J; Ge H; Yan Z; Luo B; Hu X; Yang K; Liu Y; Liu H; Zhang W
Eur Radiol; 2023 Jan; 33(1):209-220. PubMed ID: 35881182
[TBL] [Abstract][Full Text] [Related]
18. A combinatorial radiographic phenotype may stratify patient survival and be associated with invasion and proliferation characteristics in glioblastoma.
Rao A; Rao G; Gutman DA; Flanders AE; Hwang SN; Rubin DL; Colen RR; Zinn PO; Jain R; Wintermark M; Kirby JS; Jaffe CC; Freymann J;
J Neurosurg; 2016 Apr; 124(4):1008-17. PubMed ID: 26473782
[TBL] [Abstract][Full Text] [Related]
19. Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in Glioblastoma.
Grossmann P; Gutman DA; Dunn WD; Holder CA; Aerts HJ
BMC Cancer; 2016 Aug; 16():611. PubMed ID: 27502180
[TBL] [Abstract][Full Text] [Related]
20. Pre-operative MRI radiomics model non-invasively predicts key genomic markers and survival in glioblastoma patients.
Pease M; Gersey ZC; Ak M; Elakkad A; Kotrotsou A; Zenkin S; Elshafeey N; Mamindla P; Kumar VA; Kumar AJ; Colen RR; Zinn PO
J Neurooncol; 2022 Oct; 160(1):253-263. PubMed ID: 36239836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]